| Takotsubo Syndrome in the Setting of COVID-19 A Minhas, P Scheel, B Garibaldi, G Liu, M Horton, M Jennings, S Jones, ... JACC Case Rep 2 (9), 1321-1325, 2020 | 172 | 2020 |
| An observational study of outcomes and tolerances in patients with cystic fibrosis initiated on lumacaftor/ivacaftor MT Jennings, R Dezube, S Paranjape, NE West, G Hong, A Braun, ... Annals of the American Thoracic Society 14 (11), 1662-1666, 2017 | 83 | 2017 |
| Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function … MA Mall, R Brugha, S Gartner, J Legg, A Moeller, P Mondejar-Lopez, ... American journal of respiratory and critical care medicine 206 (11), 1361-1369, 2022 | 60 | 2022 |
| Risk factors for persistent Aspergillus respiratory isolation in cystic fibrosis G Hong, KJ Psoter, MT Jennings, CA Merlo, MP Boyle, D Hadjiliadis, ... Journal of Cystic Fibrosis 17 (5), 624-630, 2018 | 55 | 2018 |
| Cystic fibrosis transmembrane conductance regulator modulators reduce the risk of recurrent acute pancreatitis among adult patients with pancreas sufficient cystic fibrosis VS Akshintala, A Kamal, M Faghih, GR Cutting, L Cebotaru, NE West, ... Pancreatology 19 (8), 1023-1026, 2019 | 43 | 2019 |
| Eradication of persistent methicillin-resistant Staphylococcus aureus infection in cystic fibrosis R Dezube, MT Jennings, M Rykiel, M Diener-West, MP Boyle, JF Chmiel, ... Journal of Cystic Fibrosis 18 (3), 357-363, 2019 | 41 | 2019 |
| Frequency of small-colony variants and antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus in cystic fibrosis patients N Suwantarat, M Rubin, L Bryan, T Tekle, MP Boyle, KC Carroll, ... Diagnostic Microbiology and Infectious Disease 90 (4), 296-299, 2018 | 37 | 2018 |
| Risk factors for persistent methicillin-resistant Staphylococcus aureus infection in cystic fibrosis MT Jennings, EC Dasenbrook, N Lechtzin, MP Boyle, CA Merlo Journal of Cystic Fibrosis 16 (6), 681-686, 2017 | 31 | 2017 |
| Update on key emerging challenges in cystic fibrosis MT Jennings, KA Riekert, MP Boyle Medical Principles and Practice 23 (5), 393-402, 2014 | 30 | 2014 |
| Eradication strategy for persistent methicillin-resistant Staphylococcus aureus infection in individuals with cystic fibrosis—the PMEP trial: study protocol for a … MT Jennings, MP Boyle, D Weaver, KA Callahan, EC Dasenbrook Trials 15, 1-9, 2014 | 28 | 2014 |
| Cystic fibrosis: translating molecular mechanisms into effective therapies MT Jennings, PA Flume Annals of the American Thoracic Society 15 (8), 897-902, 2018 | 19 | 2018 |
| Effect of elexacaftor/tezacaftor/ivacaftor on annual rate of lung function decline in people with cystic fibrosis T Lee, GS Sawicki, J Altenburg, SJ Millar, JM Geiger, MT Jennings, Y Lou, ... Journal of Cystic Fibrosis 22 (3), 402-406, 2023 | 18 | 2023 |
| Out-of-clinic measurement of sweat chloride using a wearable sensor during low-intensity exercise DH Choi, GB Kitchen, MT Jennings, GR Cutting, PC Searson NPJ digital medicine 3 (1), 49, 2020 | 18 | 2020 |
| Sex differences in treatment patterns in cystic fibrosis pulmonary exacerbations K Montemayor, KJ Psoter, N Lechtzin, SW Carson, CA Merlo, RH Dezube, ... Journal of Cystic Fibrosis 20 (6), 920-925, 2021 | 14 | 2021 |
| 170 Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least one F508del allele: 144-week interim results from an open … M Griese, E Tullis, M Chilvers, B Fabrizzi, R Jain, J Legg, M Mall, ... Journal of Cystic Fibrosis 21, S99-S100, 2022 | 9 | 2022 |
| Vitamin D deficiency is associated with increased nontuberculous mycobacteria risk in cystic fibrosis WJ Richter, Y Sun, KJ Psoter, MN Santos, JA Nguyen, A Sidhaye, ... Annals of the American Thoracic Society 18 (5), 913-916, 2021 | 6 | 2021 |
| Poster session abstracts: safety and pharmacokinetics of inhaled vancomycin in individuals with cystic fibrosis M Jennings, C Bucur, MP Boyle, M Konstan, EC Dasenbrook Pediatr Pulmonol 47 (223), 446, 2012 | 6 | 2012 |
| Year in review 2017: Interventional pulmonology, lung cancer, pleural disease and respiratory infections L Yarmus, PT Nguyen, K Montemayor, M Jennings, B Bade, M Shafiq, ... J Regulation 23, 628-635, 2018 | 5 | 2018 |
| Sex differences in pulmonary exacerbations in cystic fibrosis patients K Montemayor, R Dezube, N Lechtzin, M Jennings, A Thaxton, S Allgood, ... D23. ADULT CF AND NON-CF BRONCHIECTASIS, A6267-A6267, 2018 | 3 | 2018 |
| Safety and pharmacokinetics of inhaled vancomycin in individuals with cystic fibrosis M Jennings, C Bucur, MP Boyle, M Konstan, EC Dasenbrook Pediatric Pulmonology 47, 320-320, 2012 | 3 | 2012 |
